<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36937308</PMID><DateRevised><Year>2023</Year><Month>03</Month><Day>21</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-302X</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in microbiology</Title><ISOAbbreviation>Front Microbiol</ISOAbbreviation></Journal><ArticleTitle>Altered cell function and increased replication of rhinoviruses and EV-D68 in airway epithelia of asthma patients.</ArticleTitle><Pagination><StartPage>1106945</StartPage><MedlinePgn>1106945</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1106945</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmicb.2023.1106945</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Rhinovirus (RV) infections constitute one of the main triggers of asthma exacerbations and an important burden in pediatric yard. However, the mechanisms underlying this association remain poorly understood.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">In the present study, we compared infections of <i>in vitro</i> reconstituted airway epithelia originating from asthmatic versus healthy donors with representative strains of RV-A major group and minor groups, RV-C, RV-B, and the respiratory enterovirus EV-D68.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">We found that viral replication was higher in tissues derived from asthmatic donors for all tested viruses. Viral receptor expression was comparable in non-infected tissues from both groups. After infection, ICAM1 and LDLR were upregulated, while CDHR3 was downregulated. Overall, these variations were related to viral replication levels. The presence of the CDHR3 asthma susceptibility allele (rs6967330) was not associated with increased RV-C replication. Regarding the tissue response, a significantly higher interferon (IFN) induction was demonstrated in infected tissues derived from asthmatic donors, which excludes a defect in IFN-response. Unbiased transcriptomic comparison of asthmatic versus control tissues revealed significant modifications, such as alterations of cilia structure and motility, in both infected and non-infected tissues. These observations were supported by a reduced mucociliary clearance and increased mucus secretion in non-infected tissues from asthmatic donors.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="UNASSIGNED">Altogether, we demonstrated an increased permissiveness and susceptibility to RV and respiratory EV infections in HAE derived from asthmatic patients, which was associated with a global alteration in epithelial cell functions. These results unveil the mechanisms underlying the pathogenesis of asthma exacerbation and suggest interesting therapeutic targets.</AbstractText><CopyrightInformation>Copyright © 2023 Essaidi-Laziosi, Royston, Boda, Pérez-Rodriguez, Piuz, Hulo, Kaiser, Clément, Huang, Constant and Tapparel.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Essaidi-Laziosi</LastName><ForeName>Manel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Molecular Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Royston</LastName><ForeName>Léna</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Molecular Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boda</LastName><ForeName>Bernadett</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Epithelix Sàrl, Plan les Ouates, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pérez-Rodriguez</LastName><ForeName>Francisco Javier</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Molecular Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Diseases, Geneva University Hospital, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piuz</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Molecular Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hulo</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Service for Biomathematical and Biostatistical Analyses, Institute of Genetics and Genomics, University of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaiser</LastName><ForeName>Laurent</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Geneva University Hospital, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clément</LastName><ForeName>Sophie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Molecular Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Song</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Epithelix Sàrl, Plan les Ouates, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Constant</LastName><ForeName>Samuel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Epithelix Sàrl, Plan les Ouates, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tapparel</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Molecular Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Microbiol</MedlineTA><NlmUniqueID>101548977</NlmUniqueID><ISSNLinking>1664-302X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">airway epithelial barrier</Keyword><Keyword MajorTopicYN="N">asthma</Keyword><Keyword MajorTopicYN="N">enterovirus-D68</Keyword><Keyword MajorTopicYN="N">rhinovirus</Keyword><Keyword MajorTopicYN="N">viral replication</Keyword></KeywordList><CoiStatement>BB, SH and SaC are employed by Epithelix company. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>20</Day><Hour>4</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36937308</ArticleId><ArticleId IdType="pmc">PMC10014885</ArticleId><ArticleId IdType="doi">10.3389/fmicb.2023.1106945</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Adivitiya Kaushik M. S., Chakraborty S., Veleri S., Kateriya S. (2021). Mucociliary respiratory epithelium integrity in molecular defense and susceptibility to pulmonary viral infections. Biology (Basel) 10:95. doi: 10.3390/biology10020095, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology10020095</ArticleId><ArticleId IdType="pmc">PMC7911113</ArticleId><ArticleId IdType="pubmed">33572760</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambrosioni J., Bridevaux P. O., Wagner G., Mamin A., Kaiser L. (2014). Epidemiology of viral respiratory infections in a tertiary care Centre in the era of molecular diagnosis, Geneva, Switzerland, 2011–2012. Clin. Microbiol. Infect. 20, O578–O584. doi: 10.1111/1469-0691.12525, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1469-0691.12525</ArticleId><ArticleId IdType="pmc">PMC7128668</ArticleId><ArticleId IdType="pubmed">24382326</ArticleId></ArticleIdList></Reference><Reference><Citation>Baraldo S., Contoli M., Bazzan E., Turato G., Padovani A., Marku B., et al. . (2012). Deficient antiviral immune responses in childhood: distinct roles of atopy and asthma. J. Allergy Clin. Immunol. 130, 1307–1314. doi: 10.1016/j.jaci.2012.08.005, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2012.08.005</ArticleId><ArticleId IdType="pubmed">22981791</ArticleId></ArticleIdList></Reference><Reference><Citation>Basnet S., Bochkov Y. A., Brockman-Schneider R. A., Kuipers I., Aesif S. W., Jackson D. J., et al. . (2019). CDHR3 asthma-risk genotype affects susceptibility of airway epithelium to rhinovirus C infections. Am. J. Respir. Cell Mol. Biol. 61, 450–458. doi: 10.1165/rcmb.2018-0220OC, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2018-0220OC</ArticleId><ArticleId IdType="pmc">PMC6775945</ArticleId><ArticleId IdType="pubmed">30916989</ArticleId></ArticleIdList></Reference><Reference><Citation>Bianco A., Whiteman S. C., Sethi S. K., Allen J. T., Knight R. A., Spiteri M. A. (2000). Expression of intercellular adhesion molecule-1 (ICAM-1) in nasal epithelial cells of atopic subjects: a mechanism for increased rhinovirus infection? Clin. Exp. Immunol. 121, 339–345. doi: 10.1046/j.1365-2249.2000.01301.x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2249.2000.01301.x</ArticleId><ArticleId IdType="pmc">PMC1905704</ArticleId><ArticleId IdType="pubmed">10931151</ArticleId></ArticleIdList></Reference><Reference><Citation>Bochkov Y. A., Gern J. E. (2016). Rhinoviruses and their receptors: implications for allergic disease. Curr. Allergy Asthma Rep. 16:30. doi: 10.1007/s11882-016-0608-7, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11882-016-0608-7</ArticleId><ArticleId IdType="pmc">PMC4854667</ArticleId><ArticleId IdType="pubmed">26960297</ArticleId></ArticleIdList></Reference><Reference><Citation>Bochkov Y. A., Watters K., Ashraf S., Griggs T. F., Devries M. K., Jackson D. J., et al. . (2015). Cadherin-related family member 3, a childhood asthma susceptibility gene product, mediates rhinovirus C binding and replication. Proc. Natl. Acad. Sci. U. S. A. 112, 5485–5490. doi: 10.1073/pnas.1421178112, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1421178112</ArticleId><ArticleId IdType="pmc">PMC4418890</ArticleId><ArticleId IdType="pubmed">25848009</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonnelykke K., Coleman A. T., Evans M. D., Thorsen J., Waage J., Vissing N. H., et al. . (2018). Cadherin-related family member 3 genetics and rhinovirus C respiratory illnesses. Am. J. Respir. Crit. Care Med. 197, 589–594. doi: 10.1164/rccm.201705-1021OC, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201705-1021OC</ArticleId><ArticleId IdType="pmc">PMC6005238</ArticleId><ArticleId IdType="pubmed">29121479</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonnelykke K., Sleiman P., Nielsen K., Kreiner-Moller E., Mercader J. M., Belgrave D., et al. . (2014). A genome-wide association study identifies CDHR3 as a susceptibility locus for early childhood asthma with severe exacerbations. Nat. Genet. 46, 51–55. doi: 10.1038/ng.2830, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2830</ArticleId><ArticleId IdType="pubmed">24241537</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi T., Devries M., Bacharier L. B., Busse W., Camargo C. A., Jr., Cohen R., et al. . (2021). Enhanced neutralizing antibody responses to rhinovirus C and age-dependent patterns of infection. Am. J. Respir. Crit. Care Med. 203, 822–830. doi: 10.1164/rccm.202010-3753OC, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202010-3753OC</ArticleId><ArticleId IdType="pmc">PMC8017585</ArticleId><ArticleId IdType="pubmed">33357024</ArticleId></ArticleIdList></Reference><Reference><Citation>Contoli M., Message S. D., Laza-Stanca V., Edwards M. R., Wark P. A., Bartlett N. W., et al. . (2006). Role of deficient type III interferon-lambda production in asthma exacerbations. Nat. Med. 12, 1023–1026. doi: 10.1038/nm1462, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1462</ArticleId><ArticleId IdType="pubmed">16906156</ArticleId></ArticleIdList></Reference><Reference><Citation>Corne J. M., Marshall C., Smith S., Schreiber J., Sanderson G., Holgate S. T., et al. . (2002). Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet 359, 831–834. doi: 10.1016/S0140-6736(02)07953-9, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(02)07953-9</ArticleId><ArticleId IdType="pubmed">11897281</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Silva J., Hilzendeger C., Moermans C., Schleich F., Henket M., Kebadze T., et al. . (2017). Raised interferon-beta, type 3 interferon and interferon-stimulated genes-evidence of innate immune activation in neutrophilic asthma. Clin. Exp. Allergy 47, 313–323. doi: 10.1111/cea.12809, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cea.12809</ArticleId><ArticleId IdType="pubmed">27622317</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhariwal J., Cameron A., Wong E., Paulsen M., Trujillo-Torralbo M. B., Del Rosario A., et al. . (2021). Pulmonary innate lymphoid cell responses during rhinovirus-induced asthma exacerbations in vivo: a clinical trial. Am. J. Respir. Crit. Care Med. 204, 1259–1273. doi: 10.1164/rccm.202010-3754OC, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202010-3754OC</ArticleId><ArticleId IdType="pmc">PMC8786078</ArticleId><ArticleId IdType="pubmed">34469272</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin A., Davis C. A., Schlesinger F., Drenkow J., Zaleski C., Jha S., et al. . (2013). STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21. doi: 10.1093/bioinformatics/bts635, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts635</ArticleId><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolganiuc A., Kodys K., Marshall C., Saha B., Zhang S., Bala S., et al. . (2012). Type III interferons, IL-28 and IL-29, are increased in chronic HCV infection and induce myeloid dendritic cell-mediated FoxP3+ regulatory T cells. PLoS One 7:e44915. doi: 10.1371/journal.pone.0044915, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0044915</ArticleId><ArticleId IdType="pmc">PMC3468613</ArticleId><ArticleId IdType="pubmed">23071503</ArticleId></ArticleIdList></Reference><Reference><Citation>Duerr C. U., Mccarthy C. D., Mindt B. C., Rubio M., Meli A. P., Pothlichet J., et al. . (2016). Type I interferon restricts type 2 immunopathology through the regulation of group 2 innate lymphoid cells. Nat. Immunol. 17, 65–75. doi: 10.1038/ni.3308, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3308</ArticleId><ArticleId IdType="pmc">PMC9135352</ArticleId><ArticleId IdType="pubmed">26595887</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards M. R., Regamey N., Vareille M., Kieninger E., Gupta A., Shoemark A., et al. . (2013). Impaired innate interferon induction in severe therapy resistant atopic asthmatic children. Mucosal Immunol. 6, 797–806. doi: 10.1038/mi.2012.118, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mi.2012.118</ArticleId><ArticleId IdType="pmc">PMC3684776</ArticleId><ArticleId IdType="pubmed">23212197</ArticleId></ArticleIdList></Reference><Reference><Citation>Essaidi-Laziosi M., Brito F., Benaoudia S., Royston L., Cagno V., Fernandes-Rocha M., et al. . (2018). Propagation of respiratory viruses in human airway epithelia reveals persistent virus-specific signatures. J. Allergy Clin. Immunol. 141, 2074–2084. doi: 10.1016/j.jaci.2017.07.018, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2017.07.018</ArticleId><ArticleId IdType="pmc">PMC7112338</ArticleId><ArticleId IdType="pubmed">28797733</ArticleId></ArticleIdList></Reference><Reference><Citation>Essaidi-Laziosi M., Geiser J., Huang S., Constant S., Kaiser L., Tapparel C. (2020). Interferon-dependent and respiratory virus-specific interference in dual infections of airway epithelia. Sci. Rep. 10:10246. doi: 10.1038/s41598-020-66748-6, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-66748-6</ArticleId><ArticleId IdType="pmc">PMC7314816</ArticleId><ArticleId IdType="pubmed">32581261</ArticleId></ArticleIdList></Reference><Reference><Citation>Essaidi-Laziosi M., Shevtsova A. S., Roux L. (2014). Minimal features of efficient incorporation of the hemagglutinin-neuraminidase protein into Sendai virus particles. J. Virol. 88, 303–313. doi: 10.1128/JVI.02041-13, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02041-13</ArticleId><ArticleId IdType="pmc">PMC3911711</ArticleId><ArticleId IdType="pubmed">24155372</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans C. M., Kim K., Tuvim M. J., Dickey B. F. (2009). Mucus hypersecretion in asthma: causes and effects. Curr. Opin. Pulm. Med. 15, 4–11. doi: 10.1097/MCP.0b013e32831da8d3, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCP.0b013e32831da8d3</ArticleId><ArticleId IdType="pmc">PMC2709596</ArticleId><ArticleId IdType="pubmed">19077699</ArticleId></ArticleIdList></Reference><Reference><Citation>Everman J. L., Sajuthi S., Saef B., Rios C., Stoner A. M., Numata M., et al. . (2019). Functional genomics of CDHR3 confirms its role in HRV-C infection and childhood asthma exacerbations. J. Allergy Clin. Immunol. 144, 962–971. doi: 10.1016/j.jaci.2019.01.052, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2019.01.052</ArticleId><ArticleId IdType="pmc">PMC6766426</ArticleId><ArticleId IdType="pubmed">30930175</ArticleId></ArticleIdList></Reference><Reference><Citation>Farne H., Lin L., Jackson D. J., Rattray M., Simpson A., Custovic A., et al. . (2022). In vivo bronchial epithelial interferon responses are augmented in asthma on day 4 following experimental rhinovirus infection. Thorax 77, 929–932. doi: 10.1136/thoraxjnl-2021-217389, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2021-217389</ArticleId><ArticleId IdType="pubmed">35790388</ArticleId></ArticleIdList></Reference><Reference><Citation>Filipe I. C., Tee H. K., Prados J., Piuz I., Constant S., Huang S., et al. . (2022). Comparison of tissue tropism and host response to enteric and respiratory enteroviruses. PLoS Pathog. 18:e1010632. doi: 10.1371/journal.ppat.1010632, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010632</ArticleId><ArticleId IdType="pmc">PMC9286751</ArticleId><ArticleId IdType="pubmed">35789345</ArticleId></ArticleIdList></Reference><Reference><Citation>Gern J. E. (2010). The ABCs of rhinoviruses, wheezing, and asthma. J. Virol. 84, 7418–7426. doi: 10.1128/JVI.02290-09, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02290-09</ArticleId><ArticleId IdType="pmc">PMC2897627</ArticleId><ArticleId IdType="pubmed">20375160</ArticleId></ArticleIdList></Reference><Reference><Citation>Greve J. M., Davis G., Meyer A. M., Forte C. P., Yost S. C., Marlor C. W., et al. . (1989). The major human rhinovirus receptor is ICAM-1. Cells 56, 839–847. doi: 10.1016/0092-8674(89)90688-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(89)90688-0</ArticleId><ArticleId IdType="pubmed">2538243</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruzieva O., Merid S. K., Koppelman G. H., Melen E. (2021). An update on the epigenetics of asthma. Curr. Opin. Allergy Clin. Immunol. 21, 175–181. doi: 10.1097/ACI.0000000000000723, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACI.0000000000000723</ArticleId><ArticleId IdType="pubmed">33620884</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansel T. T., Tunstall T., Trujillo-Torralbo M. B., Shamji B., Del-Rosario A., Dhariwal J., et al. . (2017). A comprehensive evaluation of nasal and bronchial cytokines and chemokines following experimental rhinovirus infection in allergic asthma: increased interferons (IFN-gamma and IFN-lambda) and type 2 inflammation (IL-5 and IL-13). EBioMedicine 19, 128–138. doi: 10.1016/j.ebiom.2017.03.033, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2017.03.033</ArticleId><ArticleId IdType="pmc">PMC5440599</ArticleId><ArticleId IdType="pubmed">28373098</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi F., Hayashi S., Matsuse D., Yamasaki R., Yonekura K., Kira J. I. (2018). Hopkins syndrome following the first episode of bronchial asthma associated with enterovirus D68: a case report. BMC Neurol. 18:71. doi: 10.1186/s12883-018-1075-7, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-018-1075-7</ArticleId><ArticleId IdType="pmc">PMC5966892</ArticleId><ArticleId IdType="pubmed">29792179</ArticleId></ArticleIdList></Reference><Reference><Citation>Heymann P. W., Platts-Mills T. A. E., Woodfolk J. A., Borish L., Murphy D. D., Carper H. T., et al. . (2020). Understanding the asthmatic response to an experimental rhinovirus infection: exploring the effects of blocking IgE. J. Allergy Clin. Immunol. 146, 545–554. doi: 10.1016/j.jaci.2020.01.035, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.01.035</ArticleId><ArticleId IdType="pmc">PMC7733370</ArticleId><ArticleId IdType="pubmed">32018030</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofer F., Gruenberger M., Kowalski H., Machat H., Huettinger M., Kuechler E., et al. . (1994). Members of the low density lipoprotein receptor family mediate cell entry of a minor-group common cold virus. Proc. Natl. Acad. Sci. U. S. A. 91, 1839–1842. doi: 10.1073/pnas.91.5.1839, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.91.5.1839</ArticleId><ArticleId IdType="pmc">PMC43259</ArticleId><ArticleId IdType="pubmed">8127891</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwane M. K., Prill M. M., Lu X., Miller E. K., Edwards K. M., Hall C. B., et al. . (2011). Human rhinovirus species associated with hospitalizations for acute respiratory illness in young US children. J. Infect. Dis. 204, 1702–1710. doi: 10.1093/infdis/jir634, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jir634</ArticleId><ArticleId IdType="pubmed">22013207</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson D. J., Gern J. E. (2022). Rhinovirus infections and their roles in asthma: etiology and exacerbations. J. Allergy Clin. Immunol. Pract. 10, 673–681. doi: 10.1016/j.jaip.2022.01.006, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2022.01.006</ArticleId><ArticleId IdType="pmc">PMC10314805</ArticleId><ArticleId IdType="pubmed">35074599</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson D. J., Makrinioti H., Rana B. M., Shamji B. W., Trujillo-Torralbo M. B., Footitt J., et al. . (2014). IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. Am. J. Respir. Crit. Care Med. 190, 1373–1382. doi: 10.1164/rccm.201406-1039OC, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201406-1039OC</ArticleId><ArticleId IdType="pmc">PMC4299647</ArticleId><ArticleId IdType="pubmed">25350863</ArticleId></ArticleIdList></Reference><Reference><Citation>Jazaeri S., Goldsmith A. M., Jarman C. R., Lee J., Hershenson M. B., Lewis T. C. (2021). Nasal interferon responses to community rhinovirus infections are similar in controls and children with asthma. Ann. Allergy Asthma Immunol. 126:e691, 690–695.e1. doi: 10.1016/j.anai.2021.01.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anai.2021.01.023</ArticleId><ArticleId IdType="pmc">PMC8164986</ArticleId><ArticleId IdType="pubmed">33515711</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanazawa J., Masuko H., Yatagai Y., Sakamoto T., Yamada H., Kaneko Y., et al. . (2017). Genetic association of the functional CDHR3 genotype with early-onset adult asthma in Japanese populations. Allergol. Int. 66, 563–567. doi: 10.1016/j.alit.2017.02.012, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.alit.2017.02.012</ArticleId><ArticleId IdType="pubmed">28318885</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy J. L., Shaker M., Mcmeen V., Gern J., Carper H., Murphy D., et al. . (2014). Comparison of viral load in individuals with and without asthma during infections with rhinovirus. Am. J. Respir. Crit. Care Med. 189, 532–539. doi: 10.1164/rccm.201310-1767OC, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201310-1767OC</ArticleId><ArticleId IdType="pmc">PMC3977713</ArticleId><ArticleId IdType="pubmed">24471509</ArticleId></ArticleIdList></Reference><Reference><Citation>Korematsu S., Nagashima K., Sato Y., Nagao M., Hasegawa S., Nakamura H., et al. . (2018). "spike" in acute asthma exacerbations during enterovirus D68 epidemic in Japan: a nation-wide survey. Allergol. Int. 67, 55–60. doi: 10.1016/j.alit.2017.04.003, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.alit.2017.04.003</ArticleId><ArticleId IdType="pubmed">28455155</ArticleId></ArticleIdList></Reference><Reference><Citation>Krammer S., Sicorschi Gutu C., Grund J. C., Chiriac M. T., Zirlik S., Finotto S. (2021). Regulation and function of interferon-lambda (IFNlambda) and its receptor in asthma. Front. Immunol. 12:731807. doi: 10.3389/fimmu.2021.731807, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.731807</ArticleId><ArticleId IdType="pmc">PMC8660125</ArticleId><ArticleId IdType="pubmed">34899691</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee W. M., Lemanske R. F., Jr., Evans M. D., Vang F., Pappas T., Gangnon R., et al. . (2012). Human rhinovirus species and season of infection determine illness severity. Am. J. Respir. Crit. Care Med. 186, 886–891. doi: 10.1164/rccm.201202-0330OC, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201202-0330OC</ArticleId><ArticleId IdType="pmc">PMC3530215</ArticleId><ArticleId IdType="pubmed">22923659</ArticleId></ArticleIdList></Reference><Reference><Citation>Liew K. Y., Koh S. K., Hooi S. L., Ng M. K. L., Chee H. Y., Harith H. H., et al. . (2022). Rhinovirus-induced cytokine alterations with potential implications in asthma exacerbations: a systematic review and meta-analysis. Front. Immunol. 13:782936. doi: 10.3389/fimmu.2022.782936, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.782936</ArticleId><ArticleId IdType="pmc">PMC8886024</ArticleId><ArticleId IdType="pubmed">35242128</ArticleId></ArticleIdList></Reference><Reference><Citation>Livak K. J., Schmittgen T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402–408. doi: 10.1006/meth.2001.1262</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/meth.2001.1262</ArticleId><ArticleId IdType="pubmed">11846609</ArticleId></ArticleIdList></Reference><Reference><Citation>Looi K., Buckley A. G., Rigby P. J., Garratt L. W., Iosifidis T., Zosky G. R., et al. . (2018). Effects of human rhinovirus on epithelial barrier integrity and function in children with asthma. Clin. Exp. Allergy 48, 513–524. doi: 10.1111/cea.13097, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cea.13097</ArticleId><ArticleId IdType="pubmed">29350877</ArticleId></ArticleIdList></Reference><Reference><Citation>Lutter R., Ravanetti L. (2019). Cadherin-related family member 3 (CDHR3) drives differentiation of ciliated bronchial epithelial cells and facilitates rhinovirus C infection, although with a little help. J. Allergy Clin. Immunol. 144, 926–927. doi: 10.1016/j.jaci.2019.07.021, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2019.07.021</ArticleId><ArticleId IdType="pubmed">31376404</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Rivera C., Crespo A., Pinedo-Sierra C., Garcia-Rivero J. L., Pallares-Sanmartin A., Marina-Malanda N., et al. . (2018). Mucus hypersecretion in asthma is associated with rhinosinusitis, polyps and exacerbations. Respir. Med. 135, 22–28. doi: 10.1016/j.rmed.2017.12.013, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2017.12.013</ArticleId><ArticleId IdType="pubmed">29414449</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss R. B. (2016). Enterovirus 68 infection--association with asthma. J. Allergy Clin. Immunol. Pract. 4, 226–228. doi: 10.1016/j.jaip.2015.12.013, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2015.12.013</ArticleId><ArticleId IdType="pubmed">26843407</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson M. D., Mccarthy D. J., Smyth G. K. (2010). edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139–140. doi: 10.1093/bioinformatics/btp616, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp616</ArticleId><ArticleId IdType="pmc">PMC2796818</ArticleId><ArticleId IdType="pubmed">19910308</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers D. F., Barnes P. J. (2006). Treatment of airway mucus hypersecretion. Ann. Med. 38, 116–125. doi: 10.1080/07853890600585795</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890600585795</ArticleId><ArticleId IdType="pubmed">16581697</ArticleId></ArticleIdList></Reference><Reference><Citation>Royston L., Tapparel C. (2016). Rhinoviruses and respiratory enteroviruses: not as simple as ABC. Viruses 8:16. doi: 10.3390/v8010016, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v8010016</ArticleId><ArticleId IdType="pmc">PMC4728576</ArticleId><ArticleId IdType="pubmed">26761027</ArticleId></ArticleIdList></Reference><Reference><Citation>Sopel N., Pflaum A., Kolle J., Finotto S. (2017). The unresolved role of interferon-lambda in asthma Bronchiale. Front. Immunol. 8:989. doi: 10.3389/fimmu.2017.00989, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.00989</ArticleId><ArticleId IdType="pmc">PMC5559474</ArticleId><ArticleId IdType="pubmed">28861088</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes A., Macintyre J., Edwards M. R., Del Rosario A., Haas J., Gielen V., et al. . (2014). Rhinovirus-induced interferon production is not deficient in well controlled asthma. Thorax 69, 240–246. doi: 10.1136/thoraxjnl-2012-202909</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2012-202909</ArticleId><ArticleId IdType="pubmed">24127021</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapparel C., Cordey S., Junier T., Farinelli L., Van Belle S., Soccal P. M., et al. . (2011). Rhinovirus genome variation during chronic upper and lower respiratory tract infections. PLoS One 6:e21163. doi: 10.1371/journal.pone.0021163, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0021163</ArticleId><ArticleId IdType="pmc">PMC3119694</ArticleId><ArticleId IdType="pubmed">21713005</ArticleId></ArticleIdList></Reference><Reference><Citation>Veerati P. C., Troy N. M., Reid A. T., Li N. F., Nichol K. S., Kaur P., et al. . (2020). Airway epithelial cell immunity is delayed during rhinovirus infection in asthma and COPD. Front. Immunol. 11:974. doi: 10.3389/fimmu.2020.00974, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00974</ArticleId><ArticleId IdType="pmc">PMC7243842</ArticleId><ArticleId IdType="pubmed">32499788</ArticleId></ArticleIdList></Reference><Reference><Citation>Xatzipsalti M., Psarros F., Konstantinou G., Gaga M., Gourgiotis D., Saxoni-Papageorgiou P., et al. . (2008). Modulation of the epithelial inflammatory response to rhinovirus in an atopic environment. Clin. Exp. Allergy 38, 466–472. doi: 10.1111/j.1365-2222.2007.02906.x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2222.2007.02906.x</ArticleId><ArticleId IdType="pubmed">18269670</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao C., Puddicombe S. M., Field S., Haywood J., Broughton-Head V., Puxeddu I., et al. . (2011). Defective epithelial barrier function in asthma. J. Allergy Clin. Immunol. 128, 549–556.e12. doi: 10.1016/j.jaci.2011.05.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2011.05.038</ArticleId><ArticleId IdType="pubmed">21752437</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z., Mitlander H., Vuorinen T., Finotto S. (2021). Mechanism of rhinovirus immunity and asthma. Front. Immunol. 12:731846. doi: 10.3389/fimmu.2021.731846, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.731846</ArticleId><ArticleId IdType="pmc">PMC8526928</ArticleId><ArticleId IdType="pubmed">34691038</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu G., Wang L. G., Han Y., He Q. Y. (2012). clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284–287. doi: 10.1089/omi.2011.0118, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/omi.2011.0118</ArticleId><ArticleId IdType="pmc">PMC3339379</ArticleId><ArticleId IdType="pubmed">22455463</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Ma K. L., Ruan X. Z., Liu B. C. (2016). Dysregulation of the low-density lipoprotein receptor pathway is involved in lipid disorder-mediated organ injury. Int. J. Biol. Sci. 12, 569–579. doi: 10.7150/ijbs.14027, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.14027</ArticleId><ArticleId IdType="pmc">PMC4807419</ArticleId><ArticleId IdType="pubmed">27019638</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J., Message S. D., Mallia P., Kebadze T., Contoli M., Ward C. K., et al. . (2019). Bronchial mucosal IFN-alpha/beta and pattern recognition receptor expression in patients with experimental rhinovirus-induced asthma exacerbations. J. Allergy Clin. Immunol. 143:e114, 114–125.e4. doi: 10.1016/j.jaci.2018.04.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2018.04.003</ArticleId><ArticleId IdType="pmc">PMC6320262</ArticleId><ArticleId IdType="pubmed">29698627</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>